MedImmune announced that it has begun shipping the 2009–2010 formulation of FluMist (intranasal, live, attenuated influenza vaccine) to vaccine distributors who service healthcare providers. MedImmune expects to produce approximately 10 million doses of FluMist for the 2009–2010 influenza season.

is a trivalent, live, attenuated influenza virus vaccine in a nasal spray formulation indicated for active immunization of individuals 2–49 years of age against influenza virus types A and B.

For more information call (800) 949-3789 or visit